Ingvas 10mg Tablet contains Rosuvastatin, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and enhancing clearance of LDL particles from the bloodstream. Ingvas 10mg is prescribed as part of a comprehensive management plan that includes diet, exercise, and lifestyle modifications to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and atherosclerosis in patients with established cardiovascular disease or those at high risk. The tablet is administered orally, typically once daily, with or without food. Dosage adjustments may be necessary based on individual patient response and tolerability. Common adverse effects include headache, myalgia, and gastrointestinal disturbances; however, serious side effects such as myopathy and hepatotoxicity are rare but warrant monitoring. Regular liver function tests and lipid profiles are recommended during therapy to ensure safety and efficacy.